Despite the evidence from preclinical mechanistic studies and human genetics about the potential involvement of TLR4 in the perpetuation of RA synovitis, NI-0101, a humanized mAb against TLR4, failed to improve arthritis in RA patients with an inadequate response to methotrexate [89]. The gene discussed is TLR4; the disease is arthritic joint disease.